| Vol. 11.37 – 22 September, 2022 |
| |
|
|
| Scientists identified that Neisseria spp. within the bronchiectasis bacteriome was associated with poorer clinical outcomes, promoting the loss of epithelial integrity and inflammation in primary epithelial cells. [Cell Host & Microbe] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Researchers demonstrated that pyruvate kinase M2 (PKM2) promoted pulmonary fibrosis progression by directly interacting with Smad7 and reinforcing transforming growth factor–β1 (TGF-β1) signaling. [Science Advances] |
|
|
|
| Scientists discovered that pulmonary neuroendocrine cells sensed succinate, which then caused short-range ATP signals to contract the myoepithelial cells wrapped around airway submucosal glands. [Developmental Cell] |
|
|
|
| Investigators explored the role of miR-378 in alveolar epithelial type II cells and identified molecular mechanisms which contributed to the pathogenesis of COPD. [Peerj] |
| |
|
|
| To investigate the underlying mechanism of ubiquitin-specific protease 22 (USP22) expression in NSCLC, researchers utilized luciferase reporters to identify potential transcription factor upregulating USP22 expression in human NSCLC cells. [Cell Communication and Signaling] |
|
|
|
| Scientists investigated three toxic compounds emitted from cooking oil fumes as human carcinogenic or mutagenic compounds to systematically evaluate the damage to cancer and healthy cells with low dose exposure. [Scientific Reports] |
|
|
|
|
| Investigators summarize the underlying mechanisms of tyrosine kinase inhibitors (TKIs) resistance and discuss the potential approaches to overcome it, aiming to provide a theoretical basis for improving the efficacy of TKIs for various cancer treatments, including NSCLC. [Signal Transduction and Targeted Therapy] |
|
|
|
|
| Over $20 million was awarded for 78 research projects being led by researchers at the University of British Columbia, including Dr. Tillie-Louise Hackett, who is studying spatial single cell Imaging in the lung. [UBC Faculty of Medicine] |
|
|
|
|
| November 6 – 8, 2022 Seville, Spain |
|
|
|
|
|
| BC Cancer Research Institute – Vancouver, British Columbia, Canada |
|
|
|
| Michigan State University – East Lansing, Michigan, United States |
|
|
|
| Stanford University – Palo Alto, California, United States |
|
|
|
| CRUK Beatson Institute for Cancer Research – Glasgow, United Kingdom |
|
|
|
| Albert Einstein College of Medicine – Bronx, New York, United States |
|
|
|
|